MX2010004639A - Formulaciones liquidas de hormona luteinizante (lh). - Google Patents
Formulaciones liquidas de hormona luteinizante (lh).Info
- Publication number
- MX2010004639A MX2010004639A MX2010004639A MX2010004639A MX2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A MX 2010004639 A MX2010004639 A MX 2010004639A
- Authority
- MX
- Mexico
- Prior art keywords
- liquid formulations
- relates
- pharmaceutical formulations
- liquid pharmaceutical
- luteinizing hormone
- Prior art date
Links
- 239000012669 liquid formulation Substances 0.000 title 1
- 102000009151 Luteinizing Hormone Human genes 0.000 abstract 2
- 108010073521 Luteinizing Hormone Proteins 0.000 abstract 2
- 229940040129 luteinizing hormone Drugs 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119832 | 2007-11-01 | ||
| US448107P | 2007-11-28 | 2007-11-28 | |
| PCT/EP2008/064679 WO2009056569A1 (en) | 2007-11-01 | 2008-10-29 | Lh liquid formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010004639A true MX2010004639A (es) | 2010-08-04 |
Family
ID=39167502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010004639A MX2010004639A (es) | 2007-11-01 | 2008-10-29 | Formulaciones liquidas de hormona luteinizante (lh). |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8664369B2 (enExample) |
| EP (1) | EP2219607B1 (enExample) |
| JP (1) | JP5551601B2 (enExample) |
| KR (1) | KR101513181B1 (enExample) |
| CN (1) | CN101842083B (enExample) |
| AU (1) | AU2008320844B2 (enExample) |
| BR (1) | BRPI0818324B8 (enExample) |
| CA (1) | CA2700662C (enExample) |
| CY (1) | CY1113121T1 (enExample) |
| DK (1) | DK2219607T3 (enExample) |
| EA (1) | EA019432B1 (enExample) |
| EC (1) | ECSP10010224A (enExample) |
| ES (1) | ES2393233T3 (enExample) |
| HR (1) | HRP20120660T1 (enExample) |
| IL (1) | IL205105A (enExample) |
| MX (1) | MX2010004639A (enExample) |
| MY (1) | MY153976A (enExample) |
| NZ (1) | NZ583991A (enExample) |
| PL (1) | PL2219607T3 (enExample) |
| PT (1) | PT2219607E (enExample) |
| RS (1) | RS52566B (enExample) |
| SI (1) | SI2219607T1 (enExample) |
| UA (1) | UA101484C2 (enExample) |
| WO (1) | WO2009056569A1 (enExample) |
| ZA (1) | ZA201001907B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ586590A (en) | 2008-01-09 | 2012-06-29 | Sanofi Aventis Deutschland | Insulin analogues or derivatives having an extremely delayed time-action profile |
| DK3228320T3 (da) | 2008-10-17 | 2020-03-09 | Sanofi Aventis Deutschland | Kombination af et insulin og en glp-1-agonist |
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| MX2012000304A (es) * | 2009-07-06 | 2012-01-27 | Sanofi Aventis Deutschland | Preparaciones insulinicas que comprenden metionina. |
| CN102711804B (zh) | 2009-11-13 | 2015-09-16 | 赛诺菲-安万特德国有限公司 | 包含glp-1激动剂和甲硫氨酸的药物组合物 |
| PL3417871T3 (pl) | 2009-11-13 | 2021-06-14 | Sanofi-Aventis Deutschland Gmbh | Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę |
| EP2533800B1 (en) * | 2010-02-12 | 2016-07-20 | Intas Pharmaceuticals Ltd. | Liquid formulation of follicle stimulating hormone |
| RU2546520C2 (ru) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| CN102293756A (zh) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | 一种尿促性素冻干粉针剂及其制备方法 |
| BR112014004726A2 (pt) | 2011-08-29 | 2017-04-04 | Sanofi Aventis Deutschland | combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| CN104870469A (zh) * | 2012-12-26 | 2015-08-26 | 沃克哈特有限公司 | 药物组合物 |
| TWI641381B (zh) | 2013-02-04 | 2018-11-21 | 法商賽諾菲公司 | 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物 |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| AU2015205620A1 (en) | 2014-01-09 | 2016-07-14 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| SG11201604708VA (en) | 2014-01-09 | 2016-07-28 | Sanofi Sa | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| AU2015205624A1 (en) | 2014-01-09 | 2016-07-14 | Sanofi | Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| ES2949095T3 (es) | 2014-12-12 | 2023-09-25 | Sanofi Aventis Deutschland | Formulación de relación fija de insulina glargina/lixisenatida |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| US5681302A (en) * | 1994-06-14 | 1997-10-28 | Minnesota Mining And Manufacturing Company | Elastic sheet-like composite |
| EP0814841B1 (en) * | 1995-03-21 | 2001-12-05 | Applied Research Systems ARS Holding N.V. | Hcg liquid formulations |
| IL122732A0 (en) * | 1997-01-15 | 1998-08-16 | Akzo Nobel Nv | Liquid gonadotropin-containing formulation its preparation and a device containing same |
| WO2000004913A1 (en) * | 1998-07-23 | 2000-02-03 | Eli Lilly And Company | Fsh and fsh variant formulations, products and methods |
| EA008038B1 (ru) * | 2003-01-08 | 2007-02-27 | Чирон Корпорейшн | Стабилизированные водные композиции, содержащие ингибитор пути метаболизма, тканевого фактора (tfpi) или вариант ингибитора пути метаболизма тканевого фактора |
| US7387998B2 (en) | 2003-03-28 | 2008-06-17 | New York University | STQ peptides |
| ATE492292T2 (de) * | 2003-04-02 | 2011-01-15 | Ares Trading Sa | Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh, das nichtionische tensid poloxamer 188 und ein antibakterielles mittel |
-
2008
- 2008-10-29 RS RS20120484A patent/RS52566B/sr unknown
- 2008-10-29 ES ES08844750T patent/ES2393233T3/es active Active
- 2008-10-29 NZ NZ583991A patent/NZ583991A/en unknown
- 2008-10-29 WO PCT/EP2008/064679 patent/WO2009056569A1/en not_active Ceased
- 2008-10-29 MY MYPI2010001950A patent/MY153976A/en unknown
- 2008-10-29 EP EP08844750A patent/EP2219607B1/en active Active
- 2008-10-29 UA UAA201006712A patent/UA101484C2/ru unknown
- 2008-10-29 CA CA2700662A patent/CA2700662C/en not_active Expired - Fee Related
- 2008-10-29 BR BRPI0818324A patent/BRPI0818324B8/pt active IP Right Grant
- 2008-10-29 CN CN2008801145250A patent/CN101842083B/zh active Active
- 2008-10-29 PL PL08844750T patent/PL2219607T3/pl unknown
- 2008-10-29 JP JP2010531519A patent/JP5551601B2/ja active Active
- 2008-10-29 AU AU2008320844A patent/AU2008320844B2/en active Active
- 2008-10-29 US US12/681,688 patent/US8664369B2/en active Active
- 2008-10-29 SI SI200830735T patent/SI2219607T1/sl unknown
- 2008-10-29 EA EA201070549A patent/EA019432B1/ru not_active IP Right Cessation
- 2008-10-29 DK DK08844750.3T patent/DK2219607T3/da active
- 2008-10-29 HR HRP20120660AT patent/HRP20120660T1/hr unknown
- 2008-10-29 MX MX2010004639A patent/MX2010004639A/es active IP Right Grant
- 2008-10-29 PT PT08844750T patent/PT2219607E/pt unknown
- 2008-10-29 KR KR1020107012131A patent/KR101513181B1/ko active Active
-
2010
- 2010-03-17 ZA ZA2010/01907A patent/ZA201001907B/en unknown
- 2010-04-15 IL IL205105A patent/IL205105A/en active IP Right Grant
- 2010-05-31 EC EC2010010224A patent/ECSP10010224A/es unknown
-
2012
- 2012-09-13 CY CY20121100836T patent/CY1113121T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY153976A (en) | Lh liquid formulations | |
| JOP20200039A1 (ar) | مُستحضر صيدلي يشتمل على hcg مأشوب | |
| EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
| WO2013188792A3 (en) | Neuroactive steroids, compositions, and uses thereof | |
| EP2152195A4 (en) | PEPTIDATE MEDICINAL FOR ORAL LEVY | |
| CL2008000690A1 (es) | Compuestos derivados del acido indol-3-propionico; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hiperlipidemia, hipertension; entre otras. | |
| UA99337C2 (ru) | Жидкая лекарственная форма фсг | |
| EP2419138A4 (en) | GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| WO2011141685A3 (fr) | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants | |
| WO2011062437A3 (ko) | 고나도트로핀 방출 호르몬 수용체 길항제, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| IN2012DN02139A (enExample) | ||
| EP2035488A4 (en) | MICELLES FOR DRUG DELIVERY | |
| EP2394648A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| DK2482881T3 (da) | Mekanisme til indretning til indlevering af lægemiddel | |
| BR112015030387A2 (pt) | compostos de pirazol como moduladores de fshr e usos dos mesmos | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| WO2007103867A3 (en) | Tablet formulations and processes | |
| TN2009000510A1 (en) | Extended release formulation of nevirapine | |
| WO2015125152A3 (en) | Pharmaceutical compositions of asenapine | |
| ZA200807348B (en) | Dosage aerosols for the administration of pharmaceutical preparations | |
| AU2009298305A8 (en) | Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (GnRH) as immunogen | |
| EP2490689A4 (en) | INJECTABLE FORMULATION FOR ADMINISTRATION IN OR NEAR RV | |
| WO2008034909A3 (en) | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin | |
| PL2114367T3 (pl) | Formulacje olopatadyny do miejscowego podawania donosowo | |
| PL2253326T3 (pl) | Kompozycja farmaceutyczna do podawania przeznosowego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |